Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28049565 | 1.00 | CYP1A2 (0.36) | CYP1A2CA12CA1CA2CA7 | |
| SCHEMBL27788667 | 0.97 | CYP1A2 (0.35) | CYP1A2CA12CA1CA2CA7 | |
| SCHEMBL28210324 | 0.97 | CYP1A2 (0.35) | CYP1A2CA12CA1CA2CA7 | |
| SCHEMBL9116152 | 0.88 | CYP1A2 (0.33) | CYP1A2CA12CA1CA2CA7 | |
| SCHEMBL27279772 | 0.87 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27526066 | 0.87 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27871138 | 0.87 | ALDH1A1 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17385578 | 0.84 | POLB (0.34) | CYP1A2CA12CA1CA2CA7 | |
| SCHEMBL7927764 | 0.84 | TSHR (0.43) | CA12CA1CA2CA7CA9 | |
| Mellitic Acid SCHEMBL27648413 | 0.83 | ALDH1A1 (0.45) | CYP1A2CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7662801-B2 | Biodegradable oxidized cellulose esters | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2010-02-16 | — | — | US | disclosed |
| US-7649089-B2 | Prepared by reacting oxidized cellulose ethers with alcohol in presence of carbodiimide coupling agent, and basic catalyst such as 4-(dimethylamino) pyridine (DMAP); emulsification; for use as binder, filler, and/or disintegrant in development of solid dosage forms; controlled release | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2010-01-19 | — | — | US | disclosed |
| US-7595392-B2 | Cellulose ether for use in drug delivery in veterinary medicine | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2009-09-29 | — | — | US | disclosed |
| US-20060093672-A1 | Biodegradable oxidized cellulose esters | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2006-05-04 | — | — | US | disclosed |
| US-20050131225-A1 | Biodegradable oxidized cellulose esters and their uses as microspheres | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-06-16 | — | — | US | disclosed |
| WO-2005047339-A1 | BIODEGRADABLE OXIDIZED CELLULOSE ESTERS AND THEIR USES AS MICROSPHERES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-05-26 | — | — | WO | disclosed |
| WO-2002053599-A2 | BIODEGRADABLE OXIDIZED CELLULOSE ESTERS | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2002-07-11 | — | — | WO | disclosed |
| US-20020086990-A1 | Biodegradable oxidized cellulose esters | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2002-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060093672-A1 | Biodegradable oxidized cellulose esters | CS, OTC, ACMSD | CYP1A2 97/4885CA12 980/4885CA1 1433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.